Tumor-reactive CD8+ T-cell clones in patients after NY-ESO-1 peptide vaccination-Reference-Cited by-同舟云学术

Tumor-reactive CD8+ T-cell clones in patients after NY-ESO-1 peptide vaccination

Published:2007 Issue:9 Volume:121 Page:2042-2048
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Karbach Julia,Gnjatic Sacha,Pauligk Claudia,Bender Armin,Maeurer Markus,Schultze Joachim L.,Nadler Kerstin,Wahle Claudia,Knuth Alexander,Old Lloyd J.,Jäger Elke

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference28 articles.

1. Simultaneous Humoral and Cellular Immune Response against Cancer–Testis Antigen NY-ESO-1: Definition of Human Histocompatibility Leukocyte Antigen (HLA)-A2–binding Peptide Epitopes

2. Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues

3. A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens

4. Humoral immune responses of cancer patients against “Cancer-Testis” antigen NY-ESO-1: Correlation with clinical events

5. Vaccine-Induced CD4+T Cell Responses to MAGE-3 Protein in Lung Cancer Patients

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity moderation effect of interleukin-24 on myelogenous leukemia cells;Anti-Cancer Drugs;2018-04

2. Mutant Epitopes in Cancer;Oncoimmunology;2017-12-14

3. In silico and cell-based analyses reveal strong divergence between prediction and observation of T-cell–recognized tumor antigen T-cell epitopes;Journal of Biological Chemistry;2017-07

4. New York esophageal squamous cell carcinoma-1 and cancer immunotherapy;Immunotherapy;2015-04

5. Enhancement of Tumor-Reactive Cytotoxic CD4+ T-cell Responses after Ipilimumab Treatment in Four Advanced Melanoma Patients;Cancer Immunology Research;2013-08-12